Opdivo Plus Yervoy Demonstrates Durable Overall Survival at Three Years Compared to Chemotherapy in First-Line Unresectable Malignant Pleural Mesothelioma in Phase 3 CheckMate -743 Trial Biotech Investing
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CXP, ECHO, INOV, TRIL; Shareholders are Encouraged to Contact the Firm Biotech Investing
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Trillium Therapeutics, Inc. - TRIL Biotech Investing
Bristol Myers Squibb Shares Research Supporting Correlation Between New York Heart Association Functional Class and Mortality in Obstructive Hypertrophic Cardiomyopathy Biotech Investing
Cardiol Therapeutics Announces Acceleration of Expiry Date of Warrants Issued on June 4, 2020 Biotech Investing
Aurinia Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference Biotech Investing
AbbVie to Highlight Its Leadership in Movement Disorders at the International Parkinson and Movement Disorder Society Virtual Congress 2021 Biotech Investing
